Inscrição na biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicou 4 edições por ano

ISSN Imprimir: 0893-9675

ISSN On-line: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Resistance to Cell Death and Its Modulation in Cancer Stem Cells

Volume 21, Edição 3-4, 2016, pp. 203-219
DOI: 10.1615/CritRevOncog.2016016976
Get accessGet access

RESUMO

Accumulating evidence has demonstrated that human cancers arise from various tissues of origin that initiate from cancer stem cells (CSCs) or cancer-initiating cells. The extrinsic and intrinsic apoptotic pathways are dysregulated in CSCs, and these cells play crucial roles in tumor initiation, progression, cell death resistance, chemo- and radiotherapy resistance, and tumor recurrence. Understanding CSC-specific signaling proteins and pathways is necessary to identify specific therapeutic targets that may lead to the development of more efficient therapies selectively targeting CSCs. Several signaling pathways−including the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR), maternal embryonic leucine zipper kinase (MELK), NOTCH1, and Wnt/Β-catenin&and expression of the CSC markers CD133, CD24, CD44, Oct4, Sox2, Nanog, and ALDH1A1 maintain CSC properties. Studying such pathways may help to understand CSC biology and lead to the development of potential therapeutic interventions to render CSCs more sensitive to cell death triggered by chemotherapy and radiation therapy. Moreover, recent demonstrations of dedifferentiation of differentiated cancer cells into CSC-like cells have created significant complexity in the CSCs hypothesis. Therefore, any successful therapeutic agent or combination of drugs for cancer therapy must eliminate not only CSCs but differentiated cancer cells and the entire bulk of tumor cells. This review article expands on the CSC hypothesis and paradigm with respect to major signaling pathways and effectors that regulate CSC apoptosis resistance. Moreover, selective CSC apoptotic modulators and their therapeutic potential for making tumors more responsive to therapy are discussed. The use of novel therapies, including small-molecule inhibitors of specific proteins in signaling pathways that regulate stemness, proliferation and migration of CSCs, immunotherapy, and noncoding microRNAs may provide better means of treating CSCs.

CITADO POR
  1. Kenda Šuster Nataša, Frković Grazio Snježana, Virant-Klun Irma, Verdenik Ivan, Smrkolj Špela, Cancer Stem Cell–Related Marker NANOG Expression in Ovarian Serous Tumors: A Clinicopathological Study of 159 Cases, International Journal of Gynecologic Cancer, 27, 9, 2017. Crossref

  2. Brown Caitlin W., Amante John J., Goel Hira Lal, Mercurio Arthur M., The α6β4 integrin promotes resistance to ferroptosis, Journal of Cell Biology, 216, 12, 2017. Crossref

  3. Moreno-Marín Nuria, Barrasa Eva, Morales-Hernández Antonio, Paniagua Beroé, Blanco-Fernández Gerardo, Merino Jaime M., Fernández-Salguero Pedro M., Dioxin Receptor Adjusts Liver Regeneration After Acute Toxic Injury and Protects Against Liver Carcinogenesis, Scientific Reports, 7, 1, 2017. Crossref

  4. Soubannier Vincent, Stifani Stefano, NF-κB Signalling in Glioblastoma, Biomedicines, 5, 2, 2017. Crossref

  5. Xu Mei, Luo Jia, Alcohol and Cancer Stem Cells, Cancers, 9, 12, 2017. Crossref

  6. Mani Saravana, Andrisani Ourania, Hepatitis B Virus-Associated Hepatocellular Carcinoma and Hepatic Cancer Stem Cells, Genes, 9, 3, 2018. Crossref

  7. Skoda Jan, Borankova Karolina, Jansson Patric J., Huang Michael L.-H., Veselska Renata, Richardson Des R., Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies, Pharmacological Research, 139, 2019. Crossref

  8. Dzobo Kevin, Senthebane Dimakatso Alice, Thomford Nicholas Ekow, Rowe Arielle, Dandara Collet, Parker M. Iqbal, Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development, OMICS: A Journal of Integrative Biology, 22, 1, 2018. Crossref

  9. Ling Kaijian, Jiang Lupin, Liang Shi, Kwong Joseph, Yang Leiyan, Li Yudi, PingYin , Deng Qingchun, Liang Zhiqing, Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system, Journal of Ovarian Research, 11, 1, 2018. Crossref

  10. Zhang Huapeng, Li Gongquan, Chen Guanghui, Zhang Yi, Pan Jie, Tang Hongwei, Li Jie, Guo Wenzhi, Zhang Shuijun, Targeting Mcl-1 inhibits survival and self-renewal of hepatocellular cancer stem-like cells, Clinics and Research in Hepatology and Gastroenterology, 43, 3, 2019. Crossref

  11. Zhang Zhi, Sun Liwei, Zhang Yixuan, Lu Guanming, Li Yongqiang, Wei Zhongheng, Long non‐coding RNA FEZF1‐AS1 promotes breast cancer stemness and tumorigenesis via targeting miR‐30a/Nanog axis, Journal of Cellular Physiology, 233, 11, 2018. Crossref

  12. Wang Zhe, Zhao Kun, Hackert Thilo, Zöller Margot, CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression, Frontiers in Cell and Developmental Biology, 6, 2018. Crossref

  13. Razaghi Ali, Heimann Kirsten, Schaeffer Patrick M., Gibson Spencer B., Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies, Apoptosis, 23, 2, 2018. Crossref

  14. Hahne Jens C., Valeri Nicola, Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors, Frontiers in Oncology, 8, 2018. Crossref

  15. Zhang Ze, Wiencke John K., Koestler Devin C., Salas Lucas A., Christensen Brock C., Kelsey Karl T., Absence of an embryonic stem cell DNA methylation signature in human cancer, BMC Cancer, 19, 1, 2019. Crossref

  16. Caldas-Lopes Eloisi, Gomez-Arteaga Alexandra, Guzman Monica L., Approaches to Targeting Cancer Stem Cells in Solid Tumors, Current Stem Cell Research & Therapy, 14, 5, 2019. Crossref

  17. Sun Hanxue, Rana Sanyukta, Wang Zhe, Zhao Kun, Schnölzer Martina, Provaznik Jan, Hackert Thilo, Lv Qingjie, Zöller Margot, The Pancreatic Cancer-Initiating Cell Marker CD44v6 Affects Transcription, Translation, and Signaling: Consequences for Exosome Composition and Delivery, Journal of Oncology, 2019, 2019. Crossref

  18. Shiga Yasuhiro, Shiga Akina, Mesci Pinar, Kwon HyoJun, Brifault Coralie, Kim John H., Jeziorski Jacob J., Nasamran Chanond, Ohtori Seiji, Muotri Alysson R., Gonias Steven L., Campana Wendy M., Tissue-type plasminogen activator-primed human iPSC-derived neural progenitor cells promote motor recovery after severe spinal cord injury, Scientific Reports, 9, 1, 2019. Crossref

  19. Varol Nuray, Konvansiyonel Kemoterapötikler ve Isı Şok Protein 90 İnhibitör Kombinasyonunun Mesane Kanseri Hücreleri Üzerine Apoptotik Etkisi, Sakarya Medical Journal, 2019. Crossref

  20. Zadorozhna Mariia, Tataranni Tiziana, Mangieri Domenica, Piperine: role in prevention and progression of cancer, Molecular Biology Reports, 46, 5, 2019. Crossref

  21. Huang Tse‐Hung, Wu Alexander T. H., Cheng Tai‐Shan, Lin Kuan‐Ting, Lai Chia‐Jou, Hsieh Hao‐Wen, Chang Peter Mu‐Hsin, Wu Cheng‐Wen, Huang Chi‐Ying F., Chen Kuan‐Yu, In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non–small‐cell lung cancer, Journal of Cellular and Molecular Medicine, 23, 12, 2019. Crossref

  22. Arif Abul, Hansen Marc F., Alander Cynthia B., Monson David K., Reimer Nickolas B., Drissi Hicham, Cancer Stem Cells and Osteosarcoma: Opportunities and Limitations, Techniques in Orthopaedics, 34, 4, 2019. Crossref

  23. Wang Hanmin, Unternaehrer Juli J., Epithelial-mesenchymal Transition and Cancer Stem Cells: At the Crossroads of Differentiation and Dedifferentiation, Developmental Dynamics, 248, 1, 2019. Crossref

  24. Liskova Alena, Kubatka Peter, Samec Marek, Zubor Pavol, Mlyncek Milos, Bielik Tibor, Samuel Samson Mathews, Zulli Anthony, Kwon Taeg Kyu, Büsselberg Dietrich, Dietary Phytochemicals Targeting Cancer Stem Cells, Molecules, 24, 5, 2019. Crossref

  25. Wang Zhe, Sun Hanxue, Provaznik Jan, Hackert Thilo, Zöller Margot, Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming, Journal of Experimental & Clinical Cancer Research, 38, 1, 2019. Crossref

  26. Han Susu, Huang Tao, Wu Xing, Wang Xiyu, Liu Shanshan, Yang Wei, Shi Qi, Li Hongjia, Hou Fenggang, Prognostic Value of CD133 and SOX2 in Advanced Cancer, Journal of Oncology, 2019, 2019. Crossref

  27. Khosla Ritu, Hemati Hamed, Rastogi Archana, Ramakrishna Gayatri, Sarin Shiv K., Trehanpati Nirupma, miR‐26b‐5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC, Liver International, 39, 9, 2019. Crossref

  28. El-Ashmawy N. E., Salem M. L., Khedr E. G., El-Zamarany E. A., Ibrahim A. O., Dual-targeted therapeutic strategy combining CSC–DC-based vaccine and cisplatin overcomes chemo-resistance in experimental mice model, Clinical and Translational Oncology, 22, 7, 2020. Crossref

  29. Assaraf Yehuda G., Brozovic Anamaria, Gonçalves Ana Cristina, Jurkovicova Dana, Linē Aija, Machuqueiro Miguel, Saponara Simona, Sarmento-Ribeiro Ana Bela, Xavier Cristina P.R., Vasconcelos M. Helena, The multi-factorial nature of clinical multidrug resistance in cancer, Drug Resistance Updates, 46, 2019. Crossref

  30. Prasad Sahdeo, Ramachandran Sharavan, Gupta Nehal, Kaushik Itishree, Srivastava Sanjay K., Cancer cells stemness: A doorstep to targeted therapy, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1866, 4, 2020. Crossref

  31. Naji Abderrahim, Favier Benoit, Deschaseaux Frédéric, Rouas-Freiss Nathalie, Eitoku Masamitsu, Suganuma Narufumi, Mesenchymal stem/stromal cell function in modulating cell death, Stem Cell Research & Therapy, 10, 1, 2019. Crossref

  32. Chang Ching-Wen, Lo Jeng-Fan, Wang Xin Wei, Roles of mitochondria in liver cancer stem cells, Differentiation, 107, 2019. Crossref

  33. Troschel Fabian M., Minte Annemarie, Ismail Yahia Mahmoud, Kamal Amr, Abdullah Mahmoud Salah, Ahmed Sarah Hamdy, Deffner Marie, Kemper Björn, Kiesel Ludwig, Eich Hans Theodor, Ibrahim Sherif Abdelaziz, Götte Martin, Greve Burkhard, Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer, International Journal of Molecular Sciences, 21, 6, 2020. Crossref

  34. Cullinane David, Gkika Karmel Sofia, Byrne Aisling, Keyes Tia E., Photostable NIR emitting ruthenium(II) conjugates; uptake and biological activity in live cells, Journal of Inorganic Biochemistry, 207, 2020. Crossref

  35. Kumar Swati, Fairmichael Ciaran, Longley Daniel B., Turkington Richard C., The Multiple Roles of the IAP Super-family in cancer, Pharmacology & Therapeutics, 214, 2020. Crossref

  36. Safa Ahmad R., Role of colorectal cancer stem cells in resistance to apoptosis and treatment in colorectal cancer, in Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies, 2020. Crossref

  37. Karki Rajendra, Sharma Bhesh Raj, Lee Ein, Banoth Balaji, Malireddi R.K. Subbarao, Samir Parimal, Tuladhar Shraddha, Mummareddy Harisankeerth, Burton Amanda R., Vogel Peter, Kanneganti Thirumala-Devi, Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer, JCI Insight, 5, 12, 2020. Crossref

  38. Lim Jin Hong, Choi Kyung Hwa, Kim Soo Young, Park Cheong Soo, Kim Seok-Mo, Park Ki Cheong, Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis, International Journal of Molecular Sciences, 21, 20, 2020. Crossref

  39. Uddin Md. Hafiz, Kim Boyun, Cho Untack, Azmi Asfar S., Song Yong Sang, Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells, Heliyon, 6, 11, 2020. Crossref

  40. Jiang Ming , Qiu Ni , Xia Haoming , Liang Hongling , Li Hongsheng , Ao Xiang , Long non‑coding RNA FOXD2‑AS1/miR‑150‑5p/PFN2 axis regulates breast cancer malignancy and tumorigenesis, International Journal of Oncology, 2019. Crossref

  41. Diana Andrea, Gaido Giuseppe, Maxia Cristina, Murtas Daniela, MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies, International Journal of Molecular Sciences, 21, 24, 2020. Crossref

  42. Ghorbani Fatemeh, Javadirad Seyed-Morteza, Amirmahani Farzane, Fatehi Zahra, Tavassoli Manoochehr, Associations of BCL2 CA-Repeat Polymorphism and Breast Cancer Susceptibility in Isfahan Province of Iran, Biochemical Genetics, 59, 2, 2021. Crossref

  43. Dutta Indrani, Dieters-Castator Dylan, Papatzimas James W., Medina Anais, Schueler Julia, Derksen Darren J., Lajoie Gilles, Postovit Lynne-Marie, Siegers Gabrielle M., ADAM protease inhibition overcomes resistance of breast cancer stem-like cells to γδ T cell immunotherapy, Cancer Letters, 496, 2021. Crossref

  44. García-Heredia José Manuel, Carnero Amancio, Role of Mitochondria in Cancer Stem Cell Resistance, Cells, 9, 7, 2020. Crossref

  45. Molina-Peña Rodolfo, Tudon-Martinez Juan Carlos, Aquines-Gutiérrez Osvaldo, A Mathematical Model of Average Dynamics in a Stem Cell Hierarchy Suggests the Combinatorial Targeting of Cancer Stem Cells and Progenitor Cells as a Potential Strategy against Tumor Growth, Cancers, 12, 9, 2020. Crossref

  46. Hoenerhoff Mark J., Boyle Molly, Minocherhomji Sheroy, Pandiri Arun R., Carcinogenesis: Mechanisms and Evaluation, in Haschek and Rousseaux's Handbook of Toxicologic Pathology, 2022. Crossref

  47. Onuma Saki, Manabe Aya, Yoshino Yuta, Matsunaga Toshiyuki, Asai Tomohiro, Ikari Akira, Upregulation of Chemoresistance by Mg2+ Deficiency through Elevation of ATP Binding Cassette Subfamily B Member 1 Expression in Human Lung Adenocarcinoma A549 Cells, Cells, 10, 5, 2021. Crossref

  48. Kopenhaver Jessica, Crutcher Madison, Waldman Scott A., Snook Adam E., The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remission, Expert Opinion on Biological Therapy, 21, 10, 2021. Crossref

  49. Uddin Faizan, Hoque Mehboob, Non-flavonoids Targeting Cancer Stem Cells: A Promising Therapeutic Avenue for Cancer Treatment, in Polyphenols-based Nanotherapeutics for Cancer Management, 2021. Crossref

  50. Fakiruddin Kamal Shaik, Lim Moon Nian, Nordin Norshariza, Rosli Rozita, Abdullah Syahril, Chemo-Sensitization of CD133+ Cancer Stem Cell Enhances the Effect of Mesenchymal Stem Cell Expressing TRAIL in Non-Small Cell Lung Cancer Cell Lines, Biology, 10, 11, 2021. Crossref

  51. Keyvani-Ghamsari Saeedeh, Khorsandi Khatereh, Rasul Azhar, Zaman Muhammad Khatir, Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance, Clinical Epigenetics, 13, 1, 2021. Crossref

  52. Lin Hsuan-Pei, Rea Matthew, Wang Zhishan, Yang Chengfeng, Down-regulation of lncRNA MEG3 promotes chronic low dose cadmium exposure-induced cell transformation and cancer stem cell-like property, Toxicology and Applied Pharmacology, 430, 2021. Crossref

  53. Manyanga Jimmy, Ganapathy Vengatesh, Bouharati Célia, Mehta Toral, Sadhasivam Balaji, Acharya Pawan, Zhao Daniel, Queimado Lurdes, Electronic cigarette aerosols alter the expression of cisplatin transporters and increase drug resistance in oral cancer cells, Scientific Reports, 11, 1, 2021. Crossref

  54. Bhat Aadil Qadir, Ayaz Mir Owais, Hossain Md Mehedi, Maqsood Aalim, Dar Mohd Jamal, Impact of ROS on Cancer and Stem Cell Growth and Therapeutics, in Handbook of Oxidative Stress in Cancer: Mechanistic Aspects, 2021. Crossref

  55. Espinosa-Bustos Christian, Mella Jaime, Soto-Delgado Jorge, Salas Cristian O, State of the art of Smo antagonists for cancer therapy: advances in the target receptor and new ligand structures, Future Medicinal Chemistry, 11, 6, 2019. Crossref

  56. Ferretti Valeria A., León Ignacio E., Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma, Current Treatment Options in Oncology, 22, 5, 2021. Crossref

  57. Castelli Vanessa, Giordano Antonio, Benedetti Elisabetta, Giansanti Francesco, Quintiliani Massimiliano, Cimini Annamaria, d’Angelo Michele, The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death, Cancers, 13, 2, 2021. Crossref

  58. Rejano-Gordillo Claudia, Ordiales-Talavero Ana, Nacarino-Palma Ana, Merino Jaime M., González-Rico Francisco J., Fernández-Salguero Pedro M., Aryl Hydrocarbon Receptor: From Homeostasis to Tumor Progression, Frontiers in Cell and Developmental Biology, 10, 2022. Crossref

  59. Parshenkov Aleksei, Hennet Thierry, Glycosylation-Dependent Induction of Programmed Cell Death in Murine Adenocarcinoma Cells, Frontiers in Immunology, 13, 2022. Crossref

  60. Das Tirtha K., Esernio Jessica, Cagan Ross L., Restraining Network Response to Targeted Cancer Therapies Improves Efficacy and Reduces Cellular Resistance, Cancer Research, 78, 15, 2018. Crossref

  61. Bhat Aadil Qadir, Ayaz Mir Owais, Hossain Md Mehedi, Maqsood Aalim, Dar Mohd Jamal, Impact of ROS on Cancer and Stem Cell Growth and Therapeutics, in Handbook of Oxidative Stress in Cancer: Mechanistic Aspects, 2022. Crossref

  62. Cianciosi Danila, Forbes-Hernández Tamara Y., Regolo Lucia, Alvarez-Suarez José M., Quinzi Denise, Sargenti Azzurra, Bai Weibin, Tian Lingmin, Giampieri Francesca, Battino Maurizio, Manuka honey in combination with 5-Fluorouracil decreases physical parameters of colonspheres enriched with cancer stem-like cells and reduces their resistance to apoptosis, Food Chemistry, 374, 2022. Crossref

  63. Tu Shi-Ming, Guo Charles C., Chow Diana S. -L., Zacharias Niki M., Stem Cell Theory of Cancer: Implications for Drug Resistance and Chemosensitivity in Cancer Care, Cancers, 14, 6, 2022. Crossref

  64. Cortes-Dericks Lourdes, Galetta Domenico, Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight, Cancers, 14, 2, 2022. Crossref

  65. Ge Di, Gao Jia, Han Lina, Li Ying, Liu Hong‐Hong, Yang Wan‐Cheng, Chang Fen, Liu Jing, Yu Mei, Zhao Jing, Novel effects of sphingosylphosphorylcholine on the apoptosis of breast cancer via autophagy/AKT/p38 and JNK signaling, Journal of Cellular Physiology, 234, 7, 2019. Crossref

  66. Bisht Shweta, Nigam Manisha, Kunjwal Shyam S., Sergey Plygun, Mishra Abhay Prakash, Sharifi-Rad Javad, Sorrenti Valeria, Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting, Stem Cells International, 2022, 2022. Crossref

  67. Xiao Yiwei, Cao Junning, Zhang Ze, Zeng Chaoting, Ou Guomin, Shi Jihang, Liu Zhixiu, Li Yi, Deng Juan, Xu Yinzhe, Zhang Wenwen, Li Jie, Li Tong, Zhuang Hui, Lu Shichun, Xiang Kuanhui, Hepatitis B Virus Pregenomic RNA Reflecting Viral Replication in Distal Non-tumor Tissues as a Determinant of the Stemness and Recurrence of Hepatocellular Carcinoma, Frontiers in Microbiology, 13, 2022. Crossref

  68. Cao Tianyu, Lu Yuanyuan, Wang Qi, Qin Hongqiang, Li Hongwei, Guo Hao, Ge Minghui, Glass Sarah E., Singh Bhuminder, Zhang Wenyao, Dong Jiaqiang, Du Feng, Qian Airong, Tian Ye, Wang Xin, Li Cunxi, Wu Kaichun, Fan Daiming, Nie Yongzhan, Coffey Robert J., Zhao Xiaodi, A CGA/EGFR/GATA2 positive feedback circuit confers chemoresistance in gastric cancer, Journal of Clinical Investigation, 132, 6, 2022. Crossref

  69. Maggio Julián, Cabrera Maia, Armando Romina, Chinestrad Patricio, Pifano Marina, Menna Pablo Lorenzano, Gomez Daniel E., Gómez Diego L. Mengual, Rational design of PIN1 inhibitors for cancer treatment based on conformational diversity analysis and docking based virtual screening, Journal of Biomolecular Structure and Dynamics, 40, 13, 2022. Crossref

  70. Brás Rita, Sunkel Claudio E., Resende Luís Pedro, Tissue stem cells: the new actors in the aneuploidy field, Cell Cycle, 18, 16, 2019. Crossref

  71. Ghosalkar Jeevan, Sonawane Vinay, Khan Mohsina, Joshi Kalpana, Shastry Padma, Prostate Apoptosis Response-4: a Therapeutic Target for Malignant Gliomas, in Tumor Suppressor Par-4, 2021. Crossref

  72. Ghatak Shibnath, Hascall Vincent C., Karamanos Nikos, Markwald Roger R., Misra Suniti, Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance, Frontiers in Oncology, 12, 2022. Crossref

  73. FIRAT Fatma, TÜRKOĞLU Canan, OZDAL KURT Feyzan, VATANSEVER Hafize Seda, KOLON KANSERİ KÖK HÜCRELERİNDE AKTEOSİD’İN İNFLAMASYON VE/YADA APOPTOZA ETKİSİ VAR MIDIR?, Genel Tıp Dergisi, 2022. Crossref

  74. Daisy Precilla S., Biswas Indrani, Kuduvalli Shreyas S., Anitha T.S., Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?, Cellular Signalling, 95, 2022. Crossref

  75. Nayak Aadya, Warrier Neerada Meenakshi, Kumar Praveen, Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems, Stem Cell Reviews and Reports, 18, 7, 2022. Crossref

  76. Lauko Adam, Volovetz Josephine, Turaga Soumya M., Bayik Defne, Silver Daniel J., Mitchell Kelly, Mulkearns-Hubert Erin E., Watson Dionysios C., Desai Kiran, Midha Manav, Hao Jing, McCortney Kathleen, Steffens Alicia, Naik Ulhas, Ahluwalia Manmeet S., Bao Shideng, Horbinski Craig, Yu Jennifer S., Lathia Justin D., SerpinB3 drives cancer stem cell survival in glioblastoma, Cell Reports, 40, 11, 2022. Crossref

  77. Mir Suhail Ahmad, Hamid Laraibah, Bader Ghulam Nabi, Shoaib Ambreen, Rahamathulla Mohamed, Alshahrani Mohammad Y., Alam Prawez, Shakeel Faiyaz, Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review, Molecules, 27, 19, 2022. Crossref

  78. Alhaddad Lina, Osipov Andreyan N., Leonov Sergey, The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance, International Journal of Molecular Sciences, 23, 21, 2022. Crossref

  79. Iwasa Yuhei, Iwata Keisuke, Okuno Mitsuru, Sugiyama Akihiko, Nishigaki Yoichi, Ohashi Yosuke, Tanaka Takuji, Iwashita Takuji, Shimizu Masahito, Tomita Eiichi, A Case of Early-Stage Gallbladder Cancer, Positive for ALDH1A1, Which Arose from Adenomyomatosis of the Gallbladder, Diagnostics, 12, 11, 2022. Crossref

Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain